Fix Trade - state-of-art technology for a better quality of life

Navigation bar

Skip navigation

LipoPrint system

The polyacrylamide gel (PAG) based system of the electrophoretic separation of human plasma lipoproteins enables the identification and quantitative assessment of up to 12 lipoprotein fractions and their subsets. Lipoprotein analysis is performed simultaneously within a single electrophoretic separation.

The LipoPrint® LDL/HDL system, as the only comprehensive lipoprotein range assessment system, enables the quick assessment of the patient’s profile and can thereby forecast the development of his/her coronary system condition in the future. The LipoPrint LDL system is designed to assess lipoprotein cholesterol (lipoprotein fractions and sub-fractions from VLDL to HDL) in a fasting serum or plasma with a total cholesterol concentration of ≥100 mg/dl.
The elevated plasma levels of small dense LDLs naturally represent a serious risk of the premature development of coronary and cerebral atherosclerosis with all of its fatal consequences (acute myocardial infarction, stroke, etc.).
The unequivocal contribution of the LipoPrint LDL system is based on the identification and quantitative assessment of the atherogenic lipoproteins: IDLC, IDLB, and especially the identification of the so-called small dense LDLs (LDL3, LDL4, LDL5, LDL6, and LDL7 subsets), in turn representing the highly atherogenic part of the lipoprotein range.
The elevated plasma levels of small dense LDLs represent a serious risk of the premature development of coronary and cerebral atherosclerosis with all of its fatal consequences (acute myocardial infarction, stroke, etc).
The early diagnosis of these highly atherogenic lipoprotein subpopulations represents a major breakthrough in the diagnosis, treatment, and prevention of cardiovascular disorders.
The high-quality diagnosis of the highly atherogenic lipoprotein subpopulations represents a major breakthrough in the diagnosis, treatment and prevention of cardiovascular disorders.
This method has helped thousands of patients in many countries throughout the world, as has been demonstrated by the two randomly selected case studies included herein.

The LipoPrint® LDL/HDL system is compact, does not require any special adjustment of the premises, and can be deployed and operated by trained staff, and only occupies the surface area of less than 120x60 cm.

Target clients

The application of the LipoPrint® LDL system by these professional areas

  • Cardiology - the system can be used to monitor the progress of the treatment and effectiveness of early interventions;
  • Endocrinology - fast and accurate diagnosis of disorders, optional early therapy and the monitoring of type II diabetes;
  • Internal medicine - identification, application and monitoring of the treatment;
  • Preventive medicine - prevention of coronary and cardiovascular disorders;
  • General practitioners - prevention of pandemic diseases;
  • Wellness and spa centres - preventive assessment of the visitors and/or patients’ health condition;
  • Research laboratories of hospitals and schools - for the purposes of the research of cardiovascular disorders, ischemic heart diseases, atherosclerosis, hypertension, hyperlipoproteinemia, cerebrovascular diseases and other cardiovascular disorders;
  • Laboratories of non-profit and health organisations - assessment of the effectiveness of individual medications in the treatment, their short-term and long-term effectiveness and the effects on the human organism;
  • Hospitals - for endocrinology, cardiology and internal departments, for research and assessment labs. The emphasis here is naturally placed on those individuals suffering from obesity and excessive weight, diabetes of any type, smokers, people with high blood pressure and high blood cholesterol, low HDL “good” cholesterol, patients who are not physically active, individuals with excessive alcohol intake, men over 45 years of age and women over 55 years of age, the general senior population, retired population and people suffering from inherited cardiovascular disorders.

The application of the LipoPrint® LDL system by population groups

The LipoPrint® system is designed for anyone with at least two of the following risk factors, some of which can be influenced:

  • Higher age - up to 84% of those people suffering from cerebrovascular disorders are older than 65 years
  • Gender - men (45 years and older) have a higher risk of myocardial infarction compared to women (55 years and older)
  • Heritability (including all ethnic groups) – family history of the early onset of heart disease (father or brother before 55 years of age, mother or sister before 65 years of age)
  • High blood cholesterol (high total cholesterol and high LDL “bad” cholesterol) 
  • Low HDL „good“ cholesterol
  • High blood pressure - blood pressure exceeding 140/90 mmHg
  • Diabetes - in diabetic patients wherein the risk of cardiovascular disorder is the same as the risk of heart disorders with subsequent infarction in individuals with a diagnosed cardiovascular disorder. It is essential to reduce the cholesterol level under professional medical monitoring – same as in the cardiovascular patients, in order to reduce the high cardiovascular risk
  • Smoking - smokers, or non-smokers exposed to cigarette smoke, have an increased risk of heart disease
  • Physical inactivity - sedentary lifestyle, lack of physical activity
  • Obesity and overweightness - overweightness is defined by the “Body Mass Index” (BMI) within 25-29.9, obesity is a BMI higher than 30. The BMI calculation method can be found on many web pages
  • Excessive alcohol intake - excessive alcohol intake can lead to elevated blood pressure, heart failure and stroke. It can lead to the elevation of the triglyceride level, cancer or other diseases and irregular heart rhythm. Excessive alcohol intake also contributes to obesity, alcoholism, suicide and accidents
  • Stress - depends on the individual response. Some researchers have reported an association between the risk of cardiovascular diseases and stress in patients’ life, their lifestyle and socio-economic position. All of these factors may affect and intensify the existing risk factors. Example: people under stress tend to eat excessively, may start smoking or smoke more than usual
If you are ready to purchase, click here If you are interested in a diagnostic test, click here